Citation Impact
Citing Papers
Conversion of amyloid positive and negative MCI to AD over 3 years
2009
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
2009
Exercise training increases size of hippocampus and improves memory
2011 Standout
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Classification of primary progressive aphasia and its variants
2011 Standout
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition
2014
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
2009
Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
2014
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
2012
Synapses and Alzheimer's Disease
2012 StandoutNobel
Cerebrovascular disease, beta-amyloid, and cognition in aging
2011
Parkinson disease
2017 Standout
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
2010
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
2008
The Amyloid-β Pathway in Alzheimer’s Disease
2021
Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
2011
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
2008
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data
2013
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
2010
Cognitive reserve in ageing and Alzheimer's disease
2012 Standout
Plasma phospholipids identify antecedent memory impairment in older adults
2014
Vascular dementia
2015 Standout
An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease
2011
TDP43-Positive Intraneuronal Inclusions in a Patient with Motor Neuron Disease and Parkinson’s Disease
2010
Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
2009 Standout
Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology
2008
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
The clinical use of structural MRI in Alzheimer disease
2010
Alzheimer's disease
2011 Standout
Amyloid imaging in mild cognitive impairment subtypes
2009
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
2011
Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
2011
Mild Cognitive Impairment
2011 Standout
Functional network disruption in the degenerative dementias
2011
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
2011
Blood-Borne Amyloid-β Dimer Correlates with Clinical Markers of Alzheimer's Disease
2010
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
2010
Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
2010
APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging
2010
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
2014
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
2011
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies
2012
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
2013
Parkinson's disease
2009 Standout
Decoding ALS: from genes to mechanism
2016 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Longitudinal Patterns of β-Amyloid Deposition in Nondemented Older Adults
2011
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Relationship between Memory Performance and β-Amyloid Deposition at Different Stages of Alzheimer’s Disease
2012
Highly efficient water-mediated approach to access benzazoles: metal catalyst and base-free synthesis of 2-substituted benzimidazoles, benzoxazoles, and benzothiazoles
2015
Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging
2011
Alzheimer's disease
2015
Toward precision medicine in Alzheimer’s disease
2016
Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
2008
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
2011
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
2013 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
2008
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
2009
Blood protein predictors of brain amyloid for enrichment in clinical trials?
2015 StandoutNobel
Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
2009
Beta-Amyloid Deposition and the Aging Brain
2009
Brain Amyloid Imaging
2011
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden
2011
Cognition, reserve, and amyloid deposition in normal aging
2009
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Alzheimer's disease
2016 Standout
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
2012
18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
2010
Prediction of Dementia by Subjective Memory Impairment<subtitle>Effects of Severity and Temporal Association With Cognitive Impairment</subtitle><alt-title>Dementia and Subjective Memory Impairment</alt-title>
2010
Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
2008
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
2009
Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
2008
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Alzheimer's Disease
2010 Standout
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
2012
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
2009
The Amyloid State of Proteins in Human Diseases
2012 Standout
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
2010
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
2009
Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
2011
Clinical amyloid imaging in Alzheimer's disease
2011
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease
2013
The Pathobiology of Vascular Dementia
2013 Standout
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
2009
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Tau imaging: early progress and future directions
2014
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
2009
Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
2013
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
2011
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
2010
Mild cognitive impairment as a diagnostic entity
2004 Standout
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
2008
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s disease
2009
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis
2008
The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI
2013
Normal Cognitive Aging
2013 Standout
Imaging amyloid deposition in Lewy body diseases
2008
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
2012
Predicting Alzheimer disease from a blood-based biomarker profile
2016 StandoutNobel
Conversion of Imine to Oxazole and Thiazole Linkages in Covalent Organic Frameworks
2018 StandoutNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Relationships between biomarkers in aging and dementia
2009
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
2011
Plasma apolipoprotein E and Alzheimer disease risk
2011
Multistep Solid-State Organic Synthesis of Carbamate-Linked Covalent Organic Frameworks
2019 StandoutNobel
Effect ofAPOEgenotype on amyloid plaque load and gray matter volume in Alzheimer disease
2009
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
2019
Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer’s Disease Pathology in Women versus Men?
2017
Amyloid imaging in dementias with atypical presentation
2012
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Association of Lifetime Cognitive Engagement and Low β-Amyloid Deposition
2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
2012
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
2010
Molecular Imaging with PET
2008
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Subacute Ischemic Stroke Is Associated With Focal 11 C PiB Positron Emission Tomography Retention But Not With Global Neocortical Aβ Deposition
2012
Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia
2016
Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span
2015
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
2010
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
2017
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
2012
Applications of Fluorine in Medicinal Chemistry
2015 Standout
G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease
2009
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
2010
Mild Cognitive Impairment
2016
Works of C. C. Rowe being referenced
-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
2007
Relationships Between Performance on the Cogstate Brief Battery, Neurodegeneration, and A Accumulation in Cognitively Normal Older Adults and Adults with MCI
2014
Imaging β-amyloid burden in aging and dementia
2007